E N D
1. Particulate Matter and Health Effects
US Army Center for Health Promotion and Preventive Medicine GOOD AFTERNOON GENERAL,
I AM LTC TIM MALLON,
THIS BRIEFING IS TO BRIING YOU UP TO DATE ON THE CHANGES WE MADE TO THE PREGNANCY PROFILE.
NEXT SLIDE………GOOD AFTERNOON GENERAL,
I AM LTC TIM MALLON,
THIS BRIEFING IS TO BRIING YOU UP TO DATE ON THE CHANGES WE MADE TO THE PREGNANCY PROFILE.
NEXT SLIDE………
4. Particulate Health Effects
“Particulate matter” is the generic term for a broad class of physically and chemically diverse substances that exist in ambient air as discrete particles (liquid or droplets) over a wide range of sizes
Originate from a variety of stationary and mobile sources
Physical and chemical properties vary greatly with time, region, meteorology and source category
Size/sourceSize/source
5. Particulate Health Effects
EPA National Ambient Air Quality Standards: U.S Clean Air Act
EPA Administrator charged with listing pollutants, which, in the administrators judgment cause or contribute to air pollution which may be reasonably anticipated to endanger either public health or welfare and to issue air quality criteria for them
Primary standards define a level of air quality, the attainment and maintenance of which, in the judgment of the administrator, based on the criteria and allowing for an adequate margin of safety, is requisite to protect the public health
Ozone as an example particle size and health effects concern changed withtimeIncludes dust, dirt, soot, smoke, and liquid droplets
Transformation of emitted gases such as SO2 and VOCs
Effects of concern for human health include respiratory, cardiovascular disease, alterations in the bodies defense system, carcinogenesis, premature death
Ozone as an example particle size and health effects concern changed withtimeIncludes dust, dirt, soot, smoke, and liquid droplets
Transformation of emitted gases such as SO2 and VOCs
Effects of concern for human health include respiratory, cardiovascular disease, alterations in the bodies defense system, carcinogenesis, premature death
6. Particulate Health Effects
Current standards under review since 1994– Industry and the American Lung Association involved the courts to issue a final standard
“Although our understanding of health effects of PM is far from complete….
Based on epidemiological evidence of a range of “serious health effects and ambient concentrations” focus on fine and course particles
Revisions to the PM NAAQS published in the FR July 1997
Included PM 2.5
7. 1997 NAAQS Multiple legal challenges
PM 2.5 standard considered to be amply justified by “growing body of empirical evidence”
Vacated revisions to the PM 10 standard, not appealed
Industry concerned about impacts due to emissions –areas of non-compliance tracked
8. US Studies reviewed by EPA
EPA Hazardous: 505-604 ug/m3 What studies and what endpoints?
Endpoints and values:
Asthma admissions: PM 10 42.5 ug/m3
Respiratory symptoms/adults PM 10 44 ug/m3
Mortality PM 10 Up to 365 ug/m3
9. EPA NAAQS 2004 Epidemiological studies show consistent positive associations of exposure of ambient PM to with health effects including mortality and morbidity
(numerous caveats)
Public health impact large due to large number of individuals exposed
Variation in PM composition acknowledged
Levels still under debate—research funding and planning
10. Historical Issues 1930’s-1950’s : Episodic severe pollution associated with increased mortality and morbidity—London, Pennsylvania
Considered “harvesting” or mortality displacement
Cardiovascular and respiratory impacts
11. More Recent Concerns
1994 Meta analysis: Dockery and Pope
1% increase in total deaths with 10 ug/m3 increase in PM10
Mass and concentration of particle mix rather than chemical species
1% increase in inpatient admissions for respiratory/10 ug/m3
Decreases in FEV and peak flow
12. Health Effects Research Institute Health Effects Institute Research Report May 2004-- NMMAPS (20 cities)
“No threshold for all cause and cardio/respiratory mortality as low as 10 ug/m3
with a probable threshold for all other cause mortality”
But: Exposure error may obscure threshold
Various cities curves differ: statistically relevant? Random error?
Impact on composite curve
Associated with levels below ambient concentrations
13. World Health Organization 2004 WHO 2004 Meta-analysis and time series study of particulate matter
Morbidity outcomes: “Cough and increase in medication use”
Morbidity and mortality confirm NMMAPS results, limited data
WHO estimates 500,000 premature deaths due to PM
Small variations at very low levels are associated with health effects without a threshold
14. American Heart Association 2004 Plausible mechanistic pathways related to cardiovascular impacts with ambient concentrations—ranging from arrhythmias to sudden death, vaso and arterial constriction
Human studies support this
15. Research Questions
National Research Council: Research Priorities for Airborne Particulate Matter 2004:
Particulate Composition
Susceptible Subpopulations
Combined Effects
16. Deployed Troops
Particulate matter is the most ubiquitous health risk encountered in deployed settings
Levels regularly exceed US standards—sometimes by orders of magnitude
Risk not readily amenable to controls
18. PM in Deployed Settings vs. US NAAQS PM 10 24 Hr 150 ug/m3
PM 10 Annual 50 ug/m3
1 Year MEG was set at 70 ug/m3
US troops lack “susceptible” subpopulations
SWA PM not uniformly associated with co-pollutants
19. SWA PM 10 Measurements
1408/1672 samples exceed PM10 annual MEG (84%)
360 ug/m3 is the mean for OIF locations (Iraq, Kuwait, Qatar)
EPA Hazardous cut point is 425 ug/m3 (24 hr. value)
46,000 ug/m3 is the highest concentration recorded at LSA Viper in Iraq in April 2003
The next highest value is 17,000 ug/m3 at the same location the next day
20. Potential Health Implications Annual average approaches 24 hour “Hazard level”
EPA considers this level hazardous for all populations
Composition different than US PM
However, sustained exposures can overwhelm clearance mechanisms
Depending on particle size, inflammatory changes can be significant
21. Potential Health Implications Impact to DNBI
Asthmatic exacerbations
Deployed force represents a wider age and health range—Pre-existing conditions?
Relationship to chronic conditions?
22. PM 10 measurements Few controls to reduce exposure:
Reduce dust
Reduce exposure time during dust storms
Personal protective equipment
Refrain from PT during dusty periods
Administrative controls: Move !
23. PM 10 and URI in Bosnia
Statistically significant association between URI ratios and PM10 weekly maximums
Weekly averages not as strongly associated as weekly maximums
URI is a broad category
24. Unresolved Respiratory Issues
Acute Eosinophilic Pneumonia
Unexplained Bronchiolitis with Severe Respiratory Distress,
Fort Campbell Pulmonary Function Testing and Anecdotal Complaints
25. Pollutant Emissions - Atypical
26. SPOD PM 10 Levels No expected health effects (7%)
Increased likelihood of aggravation of lung conditions?? Minor respiratory effects? (73%)
Increased aggravation pre-existing conditions, minor respiratory effects…. (5%)
425 Significant risk of aggravating existing conditions, respiratory effects likely especially after increased activity, prolonged durations (16%)
*Health effects for 24 hour levels
28.
Risk assessment limited to use of information from concentration-response relationships…..broad generalizations subject to much uncertainty
Health risks are associated with exposure to PM alone or in combination with other air pollutants, compositions vary
PM 2.5 studies indicate higher risks
Impacts to mission are unclear
29.
Review the autopsies of combat casualties to determine if any inflammatory or other changes in the respiratory system are evident and unrelated to pre-existing or incidental pulmonary conditions.
Enhanced surveillance—particle size distribution, characterization, long-term patterns, relative toxicity??
Communication of risk of new-onset smoking
Consideration of personal protective equipment at least in limited circumstances
30. Recommendations
DNBI Surveillance:
Identify exposed cohorts
Given the varying levels of exposure that occur at different base camps or other deployed locations, evaluate cardiovascular and respiratory outcomes
Compare data from different locations and between cohorts with varying levels of exposure during and post deployment